A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

Scientists at the Icahn School of Medicine at Mount Sinai have discovered a possible reason why some cases of melanoma—a ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 2, 2025 — Scientists ...

The study, published in the Journal of Clinical Investigation, reveals that pyrvinium pamoate—a drug approved in the 1950s to ...

patients receive regular doses of medication aimed at shrinking tumors and slowing or stopping the growth of cancer cells by ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

For those with surface skin cancer, new technology offers a non-surgical treatment option. Dr. Muennich is among the few in ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Physician Growth Partners served as the exclusive advisor to Skin Cancer Specialists Dermatology in its evaluation, negotiation, and execution of this partnership. "It was a pleasure working with ...